Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: dual-pathway growth hormone signaling
Also known as: CJC/IPA, CJC Ipamorelin
This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.
Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.
The common CJC/IPA 10 mg SKU usually contains 5 mg of modified GRF(1-29) and 5 mg of ipamorelin. GHRH and ghrelin-receptor signaling can be complementary mechanistically but the marketed fixed formulation ratio and community schedules have not been validated in controlled human studies.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: FDA component review, current vendor listings, and community market confirmation
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.
The 10 mg total 5:5 vial is a well-established current market SKU and is also discussed on Reddit; dosing discussions there remain anecdotal and are not converted into clinical protocol claims.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention CJC-1295 No DAC + Ipamorelin or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.